Other content in this Stream
Signant Health Partner Program
Become a CRO partner today. Sponsors what to know what your competitive edge is, so let's show them. We'll make sure you are distinguished and trusted for delivering across the Signant portfolio.
Electronic Version of the Neurostatus-EDSS Improves MS Trials
University Hospital Basel, Novartis and Signant Health (formerly CRF Health) recently published our experience data on the use of the eEDSS obtained from two phase III Multiple Sclerosis trials.
TrialMax eCOA Solution Overview
Get to know TrialMax by Signant Health. A proven eCOA platform that leverages 20 years of scientific, operational, and regulatory experience.
Neuroscience eClinRO Solution
Get to know our Neuroscience eClinRO Solution. An advanced solution that enhances the accuracy and reliability of clinician-rated endpoint data.
Making eCOA Accessible for All Populations
eCOA Design Considerations: Reminders and Alarms
Understanding the Benefits of eCOA in Oncology Clinical Trials
Validating Clinical Trial Data: Paper vs. eCOA
Can eCOA be used in Pediatric Clinical Trials?
3 Protocol Considerations that Drive eCOA Design
Can Seniors Use Electronic Clinical Outcome Assessments (eCOA)?
eCOA Value: Cost Savings and Beyond
eCOA Data Quality: Site and Patient Perspectives
eCOA Impact on Data Quality
The Importance of eCOA User Experience Design
TrialMax eCOA Solution for Oncology
TrialMax eCOA Solution for Asthma Clinical Trials
TrialMax eCOA Solution for COPD Clinical Trials
TrialMax eCOA Solution for Diabetes Clinical Trials